"Baylor Scott & White Medical Center – College Station is a five-story, 143-bed hospital located on a 98-acre campus near the intersection of Texas Highway 6 and Rock Prairie Road. The medical center is a certified Advanced Primary Stroke Center and a certified Chest Pain Center as well as a Level III Trauma Center. We also have a Level III Neonatal Intensive Care Unit (NICU) designation equipped with NICVIEW™ video monitors. Additionally we have achieved the American Nurses Credentialing Center Pathway to Excellence Designation. With over 35 medical specialties, the team of healthcare professionals on the medical staff can help address your questions, from routine physicals, to more advanced concerns. Call to schedule an appointment today."

During the past decade, Baylor Scott and White Medical Center- College Station conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor Scott and White Medical Center- College Station" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Baylor Scott and White Medical Center- College Station" are "COVID-19 Pneumonia" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Baylor Scott and White Medical Center- College Station" in a lesser frequency.

Most popular intervention types in "Baylor Scott and White Medical Center- College Station" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apixaban 2.5 MG" (1 trials), "Remdesivir" (1 trials) and "Tocilizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baylor Scott and White Medical Center- College Station" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Baylor Scott and White Medical Center- College Station". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Baylor Scott and White Medical Center- College Station, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baylor Scott and White Medical Center- College Station, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".